Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFκB pathway

被引:195
作者
Choi, Byeong Hyeok [2 ,4 ]
Kim, Chang Gun [2 ,4 ]
Lim, Yoongho [3 ]
Shin, Soon Young [1 ]
Lee, Young Han [2 ]
机构
[1] Hanyang Univ, Inst Nat Sci & Technol, Ansan 426791, Gyeonggi Do, South Korea
[2] Konkuk Univ, IBST, Dept Biomed Sci & Technol, Seoul 143701, South Korea
[3] Konkuk Univ, BMIC, Div Biosci & Biotechnol, Seoul 143701, South Korea
[4] Hanyang Univ, Coll Sci & Technol, Div Mol & Life Sci, Ansan 426791, Gyeonggi Do, South Korea
关键词
curcumin; multidrug resistance; L1210 leukemia cell line; mdr1b gene; NF-kappa B; P-glycoprotein; phospbatidyinositol; 3-kinase; transcription; promoter activity;
D O I
10.1016/j.canlet.2007.10.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Curcumin, a constituent of turmeric, has anti-inflammatory, anti-carcinogenic, and chemopreventive effects in several animal tumor models. The expression of P-glycoprotein (P-gp), encoded by the mdr gene, is often associated with multidrug resistance (MDR) to unrelated chemotherapeutic drugs in cancer cells. Here, we demonstrate that curcumin down-regulates P-gp expression in multidrug-resistant L1210/Adr cells. Transfection with a series of 5'-deleted constructs of the mdr1b gene promoter indicated that a proximal region between -205 and +42 of the sequence was responsible for tile suppression of promoter activity by curcumin. This response might be associated with the inhibition of the phosphatidyinositol 3-kinase (PT3K)/Akt/nuclear factor-kappa B (NF-kappa B) signaling pathway by curcumin. Moreover, curcumin reversed the MDR of the L1210/Adr cells. Thus, curcumin can contribute to the reversal of the MDR phenotype, probably due to the Suppression of P-gp expression via the inhibition of the PI3K/Akt/NF-kappa B signaling pathway. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 29 条
[1]   Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation [J].
Aggarwal, S ;
Ichikawa, H ;
Takada, Y ;
Sandur, SK ;
Shishodia, S ;
Aggarwal, BB .
MOLECULAR PHARMACOLOGY, 2006, 69 (01) :195-206
[2]   Mechanism of activation of protein kinase B by insulin and IGF-1 [J].
Alessi, DR ;
Andjelkovic, M ;
Caudwell, B ;
Cron, P ;
Morrice, N ;
Cohen, P ;
Hemmings, BA .
EMBO JOURNAL, 1996, 15 (23) :6541-6551
[3]   P-glycoprotein: from genomics to mechanism [J].
Ambudkar, SV ;
Kimchi-Sarfaty, C ;
Sauna, ZE ;
Gottesman, MM .
ONCOGENE, 2003, 22 (47) :7468-7485
[4]   Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells [J].
Anuchapreeda, Songyot ;
Thanarattanakorn, Paftra ;
Sittipreechacharn, Sornjai ;
Tima, Singkome ;
Chanarat, Prasit ;
Limtrakul, Pornngarm .
ARCHIVES OF PHARMACAL RESEARCH, 2006, 29 (10) :866-873
[5]  
Bierhaus A, 1997, THROMB HAEMOSTASIS, V77, P772
[6]   P-glycoprotein -: Implications of metabolism of neoplastic cells and cancer therapy [J].
Breier, A ;
Barancík, M ;
Sulová, Z ;
Uhrík, B .
CURRENT CANCER DRUG TARGETS, 2005, 5 (06) :457-468
[7]   Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin [J].
Chen, YR ;
Tan, TH .
ONCOGENE, 1998, 17 (02) :173-178
[8]  
COHEN D, 1991, J BIOL CHEM, V266, P2239
[9]   Chemopreventive and therapeutic effects of curcumin [J].
Duvoix, A ;
Blasius, R ;
Delhalle, S ;
Schnekenburger, M ;
Morceau, F ;
Henry, E ;
Dicato, M ;
Diederich, M .
CANCER LETTERS, 2005, 223 (02) :181-190
[10]   STRUCTURAL AND FUNCTIONAL ANALYSES OF THE PROMOTER OF THE MURINE MULTIDRUG RESISTANCE GENE MDR3/MDRLA REVEAL A NEGATIVE ELEMENT CONTAINING THE AP-1 BINDING-SITE [J].
IKEGUCHI, M ;
TEETER, LD ;
ECKERSBERG, T ;
GANAPATHI, R ;
KUO, MT .
DNA AND CELL BIOLOGY, 1991, 10 (09) :639-649